Happy New Year 2026!

Take a look at JPT'S Last Year's Highlights and What is to Come for this Year! 

Thank you! 

As we welcome the New Year, we would like to take a moment to express our heartfelt thanks for your continued loyalty and trust in our peptide technologies. Your support has been instrumental in driving our growth and innovation, and we are grateful to be able to contribute of your scientific journey. Thank you for being a vital part of our journey. We look forward to another year of collaboration, innovation, and shared success! 

JPT’s 2025 Highlights 

The past year has been an exciting and transformative one for our company. Here are just a few highlights we’re proud to share with you: 

• A New Home: We successfully moved into our new, state-of-the-art building. This provides us with enhanced facilities to support our expanding operations and ensure the highest quality standards. We lovingly refer to it amongst ourselves as the House of Peptides (HoP). 
• A Fresh Look: To mark our relocation, we unveiled a new logo and refreshed our brand design. This reflects our evolution and our commitment to modern peptide technology as we move into a new era of peptide innovation. 
• Growing Our Team: We are delighted to welcome Zohreh Bandegani to our European business development team. Her background in pharmaceutical chemistry and sales will strengthen our presence and support for clients across the UK and Europe. 
• Knowledge Sharing: In collaboration with Zellnet, Mabtech and Merck, we proudly hosted a total of four free ELISPOT seminars in Oxford, Munich, Tübingen and Berlin, providing the scientific community with valuable insights and hands-on learning opportunities. Would you like to host one of our webinars or seminars? Please contact us! 
• Our Peptide Language: we love speaking to you in person! In the US alone, we visited more than 300 labs and had fruitful discussions, interesting feedback and many cups of coffee with you. 
• The Magic of 1001 Antigen Peptides: In early 2025, we launched more than thousands antigen peptides representing individual immune dominant epitopes for different viral, bacterial and other species; for antigen-specific immune response profiling. And many more to come. 
• We went Premium! This summer, we launched Premium Grade PepMix™ Peptide Pools , our most rigorously tested control pools to date: recurrent performance-, cytotoxicity-, endotoxin- and sterility testing to ensure the highest and trusted quality benchmarks. 
• Our Ever-Expanding Catalog: besides our antigen-covering, amyloid beta and proteomics reference peptides, we have now added a variety of different peptides to our catalog: diabetes and obesity peptides, radiosensitizers, chelating DOTA peptides, affinity tags, hydrogel-forming peptides and transduction enhancers! 
• 191 Publications This Year Alone: Our peptides are referenced across many published papers, which cover a wide range of topics! Check out the most recent additions to our list. 
• A New Application Note: Read up on The Importance of Hydrophobic Peptides for T cell Activation. 

As we move forward into the New Year, we remain committed to delivering excellence, advancing peptide research, and supporting your success every step of the way. 

We wish you a prosperous, healthy, and inspiring New Year!